New study demonstrates how high-affinity B cells 'bank' their best traits instead of rolling the dice and risking deleterious mutations, with implications for better vaccine design. A vaccine's ...
Our work shows how high-affinity B cells can bank really advantageous mutations by essentially cloning themselves rather than continuing to mutate. Perhaps we will soon be able to tailor vaccines to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results